A61K 9 - Medicinal preparations characterised by special physical form

Patents for A61K 9 - Medicinal preparations characterised by special physical form (299,044)
11/2001
11/28/2001	CN1075377C Composite mannosans peptides oral liquor
11/28/2001	CN1075376C Nose drops
11/28/2001	CN1075374C Heme antianemia medicine and preparation method
11/28/2001	CN1075372C Indomethacin adhesive plaster
11/27/2001	US6323326 Method of solubilizing, purifying, and refolding protein
11/27/2001	US6323241 Prostaglandin compositions and methods of treatment for male erectile dysfunction
11/27/2001	US6323225 Pharmaceutical composition
11/27/2001	US6323193 Bioavailable oral dosage form of cefuroxime axetil
11/27/2001	US6323189 Stable liquid composition consisting essentially of chitosan, non-fatty acid or salt thereof, and water or aqueous solution
11/27/2001	US6323182 Concentrate for use in preparation of dialysis solution comprising gluconic acid and glucose in amounts such that upon dilution with aqueous solution in ratio of at least about 1:150, specified concentrations are obtained
11/27/2001	US6323175 Composition comprising physiologically compatible liposome, hemoglobin encapsulated in liposome, and nitroxide encapsulated in liposome
11/27/2001	US6322983 Apparatus for the storage and prevention of degradation of nucleotide sequences
11/27/2001	US6322828 Cooling gum until brittle, grinding, mixing with pharmaceutical ingredient, granulating, forming into tablet; topical absorption in buccal cavity or gastrointestinal tract
11/27/2001	US6322821 Mixture containing water, propylene glycol, calcium chloride, b vitamins and minerals, other additives; raises calcium levels of a freshening cow
11/27/2001	US6322820 Composition of matter and method for the relief of hemorrhoidal conditions
11/27/2001	US6322819 Amphetamine salt covered with enteric release coating
11/27/2001	US6322818 Starch granulation
11/27/2001	US6322817 Formulations of paclitaxel, its derivatives or its analogs entrapped into nanoparticles of polymeric micelles, process for preparing same and the use thereof
11/27/2001	US6322816 Fast-acting analgesic
11/27/2001	US6322813 Compact member, method of manufacturing and use thereof
11/27/2001	US6322812 Granulation of mesna with water, compression or compaction
11/27/2001	US6322811 Alkylene oxide polymer compositions
11/27/2001	US6322810 Materials and methods for making improved micelle compositions
11/27/2001	US6322809 Containing one or more bacteria entrapped in liposome
11/27/2001	US6322808 Device for enhancing transdermal agent flux
11/27/2001	US6322806 Over-coated chewing gum formulations including tableted center
11/27/2001	US6322805 Amphiphilic block polymer having units of polyethers and polylactones
11/27/2001	US6322804 Implantable biocompatible immunoisolatory vehicle for the delivery of selected therapeutic products
11/27/2001	US6322801 Water insoluble substrate of nonwoven ply and polymeric net, cleansing component
11/27/2001	US6322800 Incorporating into fatty phase a fluoroester like 2(f-octyl)ethyl as a stabilizing agent; used in cosmetic, hygiene or pharmaceutical composition
11/27/2001	US6322798 Container closed with a cap containing ascorbic acid and perforable and/or detachable separator; toning, stimulation, regeneration, moisturizing effects, smoothness, softness attenuation of wrinkles, firmness, clarity of skin
11/27/2001	US6322797 Biodegradable terephthalate polyester-poly (phosphate) polymers, compositions, articles, and methods for making and using the same
11/27/2001	US6322493 Expanded clitoral sensitizing compounds with methods and apparatus for the delivery of these compounds
11/27/2001	US6322360 Medication retention assembly for oral delivery tray
11/27/2001	CA2245366C Transdermal patch
11/27/2001	CA2217573C Emulsion suitable for administering a poorly water-soluble photosensitizing compound and use thereof
11/27/2001	CA2184551C Iron dextran formulations
11/27/2001	CA2079685C Synthetic membrane vesicles containing functionally active fusion peptides as drug delivery systems
11/27/2001	CA2024863C The manufacture of pellets of xanthine derivatives
11/26/2001	CA2349136A1 Reactive crystallization method to improve particle size
11/26/2001	CA2309575A1 Internally cross-linked macromolecules
11/25/2001	CA2309518A1 Apoptotic entities for use in treatment of t-cell-mediated and inflammatory disorders
11/25/2001	CA2309417A1 Apoptotic entities for use in treatment of endothelium dysfunction disorders
11/22/2001	WO2001088025A1 Membranes formed from amphiphilic copolymers
11/22/2001	WO2001088019A1 Material based on biodegradable polymers and method for preparing same
11/22/2001	WO2001087913A2 Method for treating retinal degeneration with purinergic receptor agonists
11/22/2001	WO2001087841A1 Novel polymorph v of torasemide
11/22/2001	WO2001087836A1 Novel $g(b crystalline form of perindopril tert-butylamine salt, preparation method, and pharmaceutical compositions containing same
11/22/2001	WO2001087402A1 Pharmacokinetics-algorithms for controlling and regulating the consumption of various drugs
11/22/2001	WO2001087355A1 Lipophilic medicament
11/22/2001	WO2001087353A1 Preparations for diagnosing infection with helicobacter pylori
11/22/2001	WO2001087345A1 Stable polymeric micelle-type drug composition and method for the preparation thereof
11/22/2001	WO2001087344A1 Pharmaceutical and/or cosmetic composition containing an organosiloxane and a phospholipid
11/22/2001	WO2001087336A1 Cancer treatments by using a combination of an antibody against her2 and interleukin -2
11/22/2001	WO2001087329A1 Liquid pharmaceutical composition containing an erythropoietin derivate
11/22/2001	WO2001087327A1 Method for cell adhesion and wound healing
11/22/2001	WO2001087322A2 Peptide pharmaceutical formulations
11/22/2001	WO2001087304A1 Ophthalmic solution
11/22/2001	WO2001087303A1 Aqueous liquid preparation
11/22/2001	WO2001087301A1 Methods for treatment of inflammatory diseases
11/22/2001	WO2001087298A1 Water-based liquid preparation
11/22/2001	WO2001087297A1 Cannabinoid drugs
11/22/2001	WO2001087296A1 Methods for decreasing cell proliferation based on (3r, 4r)δ8-tetrahydrocannabinol-11-oic acids
11/22/2001	WO2001087295A1 Methods for decreasing cell proliferation based on (3r, 4r)-δ8-tetrahydrocannabinol-11-oic acids
11/22/2001	WO2001087289A2 Propofol for treatment of sepsis
11/22/2001	WO2001087284A2 Aldosterone antagonist composition for release during aldosterone acrophase
11/22/2001	WO2001087278A1 Insulin formulation for inhalation
11/22/2001	WO2001087277A2 Method of manufacturing particles
11/22/2001	WO2001087276A1 Hydrogel composition for transdermal drug delivery
11/22/2001	WO2001087274A2 Plaster cover for children
11/22/2001	WO2001087273A1 Delivery mechanism for the introduction of biological substances to animals
11/22/2001	WO2001087272A2 Encapsulating a toxic core within a non-toxic region in an oral dosage form
11/22/2001	WO2001087271A1 Medical dressing assembly and associated method of using the same
11/22/2001	WO2001087270A2 Vaccine composition, method of preparing the same, and method of vaccinating vertebrates
11/22/2001	WO2001087269A1 A coating composition for facilitating controlled release
11/22/2001	WO2001087268A1 Micellar pharmaceutical compositions for buccal and pulmonary application
11/22/2001	WO2001087267A1 Protein matrix materials, devices and methods of making and using thereof
11/22/2001	WO2001087266A1 Stabilized aqueous suspensions for parenteral use
11/22/2001	WO2001087265A2 Pharmaceutical form of administration for peptides, methods for its production and use
11/22/2001	WO2001087264A2 Rapidly disintegrating solid oral dosage form
11/22/2001	WO2001087262A2 Stabilized steroidal suspension
11/22/2001	WO2001087254A1 Use of ellagic acid as anti-pollution cosmetic agent
11/22/2001	WO2001087236A2 Topical administration of pharmacological compositions for non-systemic treatment of pruritus
11/22/2001	WO2001087232A2 Allantoin-containing skin cream
11/22/2001	WO2001087229A2 Treating infections
11/22/2001	WO2001087228A2 Sustained release pharmaceutical composition containing glipizide and method for producing same
11/22/2001	WO2001087227A2 Drug containing polymeric micelles
11/22/2001	WO2001047559A9 Patches for external use
11/22/2001	WO2001041770A3 Nanoparticulate eplerenone compositions
11/22/2001	WO2001037810A3 In ovo delivery of an immunogen containing implant
11/22/2001	WO2001037804A3 Preservation and formulation of bioactive materials
11/22/2001	WO2001036611A8 Process for the production of a reversibly inactive acidified plasmin composition
11/22/2001	WO2001034192A3 Improved method of immunization
11/22/2001	WO2001034185A3 Induction of mucosal immunity by vaccination via the skin route
11/22/2001	WO2001034119A3 Inhibitors of crystallization in a solid dispersion
11/22/2001	WO2001034116A3 Pharmaceutical formulations comprising labdanes for the treatment of tumors or leukemias
11/22/2001	WO2001019385A3 The use of bacterial phage associated lysing enzymes for the prophylactic and therapeutic treatment of various illnesses
11/22/2001	US20010044620 Microfabricated injectable drug delivery system
11/22/2001	US20010044583 Gas filled liposomes and their use as ultrasonic contrast agents
11/22/2001	US20010044474 Hydrogel-driven layered drug dosage form

1 ... 2341 2342 2343 2344 2345 2346 2347 2348 2349 2350 2351 2352 2353 2354 2355 2356 2357 2358 2359 2360 2361 ... 2991